Jennie Lee
About Jennie Lee
Jennie Lee serves as the Senior Manager of Analytical Development and Quality Control at Leap Therapeutics, where she has worked since 2021. She holds a Bachelor of Science in Biochemistry and Molecular Biology from Boston University and has extensive experience in quality control and analytical development across several prominent biotechnology companies.
Current Role at Leap Therapeutics
Jennie Lee serves as the Senior Manager of Analytical Development and Quality Control at Leap Therapeutics. She has held this position since 2021, contributing to the company's efforts in the biopharmaceutical sector. Her role involves overseeing analytical development processes and ensuring quality control standards are met within the organization.
Previous Experience at Moderna
Before joining Leap Therapeutics, Jennie Lee worked at Moderna as a Senior QC Specialist in Analytical Method Transfers. Her tenure lasted 11 months from 2019 to 2020, during which she was based in Norwood, Massachusetts. In this role, she focused on the transfer of analytical methods to ensure compliance and efficiency.
Experience at Sanofi
Jennie Lee was employed at Sanofi as a QC Manager in QA Technical Services from 2020 to 2021. This position lasted for one year and was located in Waltham, Massachusetts. Her responsibilities included managing quality control processes and ensuring adherence to regulatory standards.
Educational Background in Biochemistry
Jennie Lee earned her Bachelor of Science degree in Biochemistry and Molecular Biology from Boston University. Her educational background provides a strong foundation for her career in analytical development and quality control within the biopharmaceutical industry.
Career at Genzyme Corp
Jennie Lee has extensive experience at Genzyme Corp, where she held multiple positions over several years. She worked as a QC Analyst II from 2006 to 2009, then as a Senior QC Analyst in Methods Validation from 2013 to 2017. She advanced to Principal QC Analyst in Methods Validation from 2017 to 2018 and served as a Senior QC Analyst in Operations from 2009 to 2013, accumulating significant expertise in quality control processes.